Clearpoint Accounts Payable from 2010 to 2024

CLPT Stock  USD 11.67  0.17  1.44%   
Clearpoint Neuro Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 373.4 K in 2024. Accounts Payable is the amount Clearpoint Neuro owes to suppliers or vendors for products or services received but not yet paid for. It represents Clearpoint Neuro's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2011-12-31
Previous Quarter
822 K
Current Value
955 K
Quarterly Volatility
788.9 K
 
Yuan Drop
 
Covid
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 366.7 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.13, Dividend Yield of 0.0 or PTB Ratio of 8.29. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Latest Clearpoint Neuro's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Clearpoint Neuro over the last few years. An accounting item on the balance sheet that represents Clearpoint Neuro obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Clearpoint Neuro are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Clearpoint Neuro's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Clearpoint Accounts Payable Regression Statistics

Arithmetic Mean1,385,835
Geometric Mean927,234
Coefficient Of Variation93.23
Mean Deviation1,037,760
Median759,445
Standard Deviation1,292,069
Sample Variance1.7T
Range3.8M
R-Value(0.86)
Mean Square Error478.3B
R-Squared0.73
Significance0.000045
Slope(247,515)
Total Sum of Squares23.4T

Clearpoint Accounts Payable History

2024373.4 K
2023393 K
2022272 K
2021427 K
2020300 K
2019965.8 K
2018500.9 K

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable393 K373.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.